Skip to content

To check whether Kasahara Dashemani i.e, a combination of 10 ayurvedic drugs is effective in treating dry cough in children

Effect of Kasahara Dashemani in the management of Vataja Kasa in children-An open ended two arm randomised clinical study

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/06/019699
Enrollment
60
Registered
2019-06-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J399- Disease of upper respiratory tract, unspecified

Interventions

Intervention1: Kasahara Dashemani Syrup: Honey based syrup formed by combination of 10 ayurvedic drugs mentioned by Acharya Charaka. DOSE- 5to7 years - 7ml, 8 to 10 years-9ml, 11to 13 years-11ml, 14 t

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient presenting with cardinal features of vataja kasa as mentioned in classical texts. 2.Patient having vataja kasa of less than 21 days.

Exclusion criteria

Exclusion criteria: 1.Patient not presenting with cardinal features of vataja kasa as mentioned in classical texts. 2.Patient having vataja kasa as upadrava(complication) of any other disease. 3.Patient having vataja kasa of chronicity more than 21 days. 4.Patient suffering from any severe disease of lower respiratory tract.

Design outcomes

Primary

MeasureTime frame
Improvement in classical sign and symptoms of Vataja Kasa in children.Timepoint: 0 day,28th day and one during follow up.

Secondary

MeasureTime frame
Improvement in quality of life.Timepoint: o day,28th day and one during follow up;Improvement in vyadhikshamatva in children.Timepoint: 0 day,28th day and one during follow-up

Countries

India

Contacts

Public ContactDr Rajagopala Shrikrishna

All India Institute of Ayurveda

srajagopala@gmail.com7600902564

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026